Esomeprazole · Nexium

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Helicobacter pylori Infection

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

Also approved (4)
US
  • NEXIUM is a proton pump inhibitor (PPI). NEXIUM delayed-release capsules and NEXIUM for delayed-release oral suspension are indicated for the: Short-term treatment in the healing of erosive esophagitis (EE) in adults and pediatric patients 12 years to 17 years of age; maintenance of healing of EE in adults; Short-term treatment of heartburn and other symptoms associated GERD in adults and pediatric patients 12 years to 17 years of age; Risk reduction of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults at risk for developing gastric ulcers due to age (60 years and older) and/or documented history of gastric ulcers; Helicobacter pylori eradication in adult patients to reduce the risk of duodenal ulcer recurrence in combination with amoxicillin and clarithromycin; Long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults. NEXIUM for delayed-release oral suspension is indicated for the: Short-term treatment in the healing of EE in pediatric patients 1 year to 11 years of age and of EE due to acid-mediated GERD in pediatric patients 1 month to less than 1 year of age; Short-term treatment of heartburn and other symptoms associated with GERD in pediatric patients 1 year to 11 years of age.
    FDA label
  • Risk Reduction of Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Associated Gastric Ulcer NEXIUM delayed-release capsules and NEXIUM for delayed-release oral suspension are indicated for the reduction in the occurrence of gastric ulcers associated with continuous NSAID therapy in adult patients at risk for developing gastric ulcers. Patients are considered to be at risk due to their age (60 years and older) and/or documented history of gastric ulcers. Controlled studies do not extend beyond 6 months.
    FDA label
  • Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome NEXIUM delayed-release capsules and NEXIUM for delayed-release oral suspension are indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome, in adults.
    FDA label
  • Healing of Erosive Esophagitis (EE) Adults NEXIUM delayed-release capsules and NEXIUM for delayed-release oral suspension are indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed EE in adults. For those patients who have not healed after 4 to 8 weeks of treatment, an additional 4- to 8- week course of NEXIUM may be considered. Pediatric Patients 12 Years to 17 Years of Age NEXIUM delayed-release capsules and NEXIUM for delayed-release oral suspension are indicated for the short-term treatment (4 to 8 weeks) for the healing
    FDA label
Product first approved 2001Outside this platform's coverage

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (61)
Helicobacter pylori Infection
NCT06811207 · Chang Gung Memorial Hospital
2025-02-01 – 2025-02-28 · HELICOBACTER PYLORI INFECTIONS
What this study did
NCT05577468 · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
2022-10-30 – 2023-09-30 · Helicobacter Pylori Infection
What this study did
NCT01544517 · University of Campania Luigi Vanvitelli
2011-01 – 2011-12 · Helicobacter Pylori Infection
What this study did
NCT00455806 · Technische Universität Dresden
2007-01 – 2008-02 · Helicobacter Pylori Infection, Chronic Gastritis
What this study did
Other / comorbidity
NCT05267613 · AstraZeneca
2022-07-01 – 2026-08-10 · Erosive Esophagitis
What this study did
NCT06850480 · Livzon Pharmaceutical Group Inc.
2024-12-05 – 2025-04-30 · Reflux Esophagitis (RE)
What this study did
NCT03452865 · Università Vita-Salute San Raffaele
2020-01-28 – 2023-08-21 · Sepsis, Septic Shock
What this study did
NCT04652284 · Rabin Medical Center
2021-05-01 – 2023-07-31 · Helicobacter Infections, Resistance Bacterial, Gastritis H Pylori
What this study did
NCT03717740 · Aswan University Hospital
2018-12-01 – 2022-01-01 · Pre-Eclampsia
What this study did
NCT04696783 · Fifth Affiliated Hospital, Sun Yat-Sen University
2021-07 – 2021-11 · Gastroesophageal Reflux Disease
What this study did
NCT00542347 · Queen's University
2007-09 – 2018-07 · Gastric Acid
What this study did
NCT03142620 · Chinese University of Hong Kong
2015-03 – 2017-12 · H. Pylori Infection
What this study did
NCT00357682 · University of Oxford
2005-03-10 – 2017-05-31 · Esophageal Cancer, Precancerous Condition
What this study did
NCT01579539 · Medical University of Vienna
2013-06-27 – 2017-05-18 · Thyroid-associated Ophthalmopathy, Dry Eye Syndrome
What this study did
NCT01873079 · The University of Hong Kong
2013-04 – 2016-06 · Bleeding, ERCP
What this study did
NCT02767479 · Hamamatsu University
2012-07 – 2016-04 · H. Pylori Infection
What this study did
NCT02157376 · AstraZeneca
2014-07 – 2016-02 · Stress Ulcer Prophylaxis
What this study did
NCT01757275 · AstraZeneca
2013-02 – 2014-12 · Bleeding Peptic Ulcer
What this study did
NCT01142245 · Chinese University of Hong Kong
2008-01 – 2014-07 · Peptic Ulcer, Bleeding
What this study did
NCT01669811 · AstraZeneca
2012-08 – 2014-05 · Refractory Reflux Esophagitis
What this study did
NCT02037477 · Takeda
2014-01 – 2014-03 · Healthy Volunteers
What this study did
NCT01132638 · Takeda
2011-08 – 2012-06 · GERD
What this study did
NCT00206440 · Baylor Breast Care Center
2005-08 – 2012-02 · Nausea
What this study did
NCT01370525 · AstraZeneca
2011-08 – 2011-10 · Heartburn
What this study did
NCT01370538 · AstraZeneca
2011-08 – 2011-10 · Heartburn
What this study did
NCT00567658 · Vanderbilt University
2008-02 – 2010-01 · Larynx Disease
What this study did
NCT00455754 · Technische Universität Dresden
2007-02 – 2009-12 · Lymphocytic Gastritis
What this study did
NCT00994708 · Tampere University Hospital
started 2004-12 · Airway Responsiveness
What this study did
NCT00595517 · AstraZeneca
2007-10 – 2009-09 · Gastric Ulcer, Duodenal Ulcer, Rheumatoid Arthritis, Osteoarthritis, Lumbago
What this study did
NCT00699426 · Lise Tarnow
2008-06 – 2009-06 · Type 2 Diabetes
What this study did
NCT00634114 · AstraZeneca
2008-01 – 2009-05 · Reflux Esophagitis
What this study did
NCT00427635 · AstraZeneca
2006-10 – 2009-04 · GERD
What this study did
NCT00251927 · AstraZeneca
2001-10 – 2009-04 · Gastroesophageal Reflux
What this study did
NCT00542789 · AstraZeneca
2007-08 – 2009-02 · Gastric Ulcer, Duodenal Ulcer, Rheumatoid Arthritis, Osteoarthritis, Lumbago
What this study did
NCT00633932 · AstraZeneca
2007-12 – 2008-12 · Reflux Esophagitis
What this study did
NCT00401752 · AstraZeneca
2006-03 – 2008-11 · Gastric Ulcer
What this study did
NCT00164840 · Chinese University of Hong Kong
2003-05 – 2008-11 · Gastroesophageal Reflux Disease
What this study did
NCT00441727 · AstraZeneca
2007-02 – 2008-08 · Gastric Ulcer, Duodenal Ulcer
What this study did
NCT00468559 · AstraZeneca
2007-04 – 2008-06 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00251979 · AstraZeneca
2005-10 – 2007-12 · Gastrointestinal Hemorrhage
What this study did
NCT00402259 · AstraZeneca
2006-08 – 2007-10 · Gastrointestinal Hemorrhage
What this study did
NCT00243724 · AstraZeneca
2005-04 – 2007-06 · Gastroesophageal Reflux, Heartburn, Dyspepsia
What this study did
NCT00251966 · AstraZeneca
2004-05 – 2005-09 · Gastroesophageal Reflux
What this study did
NCT00079833 · AstraZeneca
2003-11 – 2005-07 · Zollinger-Ellison Syndrome
What this study did
NCT00251901 · AstraZeneca
2004-05 – 2005-07 · Chest Pain, Gastroesophageal Reflux
What this study did
NCT00365313 · Chinese University of Hong Kong
2002-08 – 2005-06 · Arthritis, Bleeding Ulcer
What this study did
NCT00241501 · AstraZeneca
2004-02 – 2005-04 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00251914 · AstraZeneca
2002-12 – 2005-01 · Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia
What this study did
Phase 2/3 (4)
Helicobacter pylori Infection
NCT05861687 · Finni Kollins
2021-08-01 – 2022-05-20 · Helicobacter Pylori Infection
What this study did
Other / comorbidity
NCT03213639 · Assiut University
2018-03-15 – 2020-10-15 · Preeclampsia
What this study did
NCT01089959 · Southern Arizona VA Health Care System
2010-03 – 2012-03 · Gastroesophageal Reflux Disease
What this study did
NCT00728481 · Mayo Clinic
2008-05 – 2010-12 · Eosinophilic Esophagitis, Gastroesophageal Reflux Disease, EE, GERD
What this study did
Phase 2 (21)
Other / comorbidity
NCT07144657 · National Taiwan University Hospital
2025-09-01 – 2030-12-31 · MALT Lymphoma of Stomach
What this study did
NCT06903585 · American University of Beirut Medical Center
2025-04 – 2029-04 · Bone Pain Flare, Bone Metastasis
What this study did
NCT03866668 · Stanford University
2019-05-29 – 2028-12 · Autism, Autism Spectrum Disorder
What this study did
NCT06120803 · Rush University Medical Center
2024-03-01 – 2028-06-30 · Radiation Esophagitis, Locally Advanced Lung Carcinoma
What this study did
NCT03625050 · Gachon University Gil Oriental Medical Hospital
2018-11-01 – 2021-05-31 · Total Knee Replacement, Manipulation
What this study did
NCT03488147 · Icahn School of Medicine at Mount Sinai
2020-07 – 2020-07-02 · Dysphagia, GERD, Degenerative Joint Disease
What this study did
NCT03428568 · King Abdullah International Medical Research Center
2018-03 – 2020-03 · Acid Dyspepsia, Gastritis
What this study did
NCT02743949 · Takeda
2016-07-14 – 2018-10-12 · Gastroesophageal Reflux
What this study did
NCT01138969 · Kaohsiung Veterans General Hospital.
2008-08 – 2012-12 · Peptic Ulcer
What this study did
NCT01983774 · Columbia University
2008-02 – 2011-08 · Cystic Fibrosis
What this study did
NCT00474903 · National Cancer Institute (NCI)
2007-04 – 2011-06 · Barrett Esophagus, Esophageal Cancer
What this study did
NCT00164788 · Chinese University of Hong Kong
2004-07 – 2011-01 · Gastrointestinal Hemorrhage
What this study did
NCT00723502 · MerLion Pharmaceuticals GmbH
2008-09 – 2009-04 · Gram-Negative Bacterial Infections, Helicobacter Infections, Dyspepsia
What this study did
NCT00317044 · AstraZeneca
2006-04 – 2008-07 · Asthma, GERD
What this study did
NCT00222131 · University of Kansas Medical Center
2003-10 – 2008-01 · Indigestion
What this study did
NCT00303264 · Forest Laboratories
2006-05 – 2007-08 · Dyspepsia
What this study did
NCT00405119 · GlaxoSmithKline
2006-05 – 2007-03 · Gastroesophageal Reflux Disease, Reflux, Gastroesophageal
What this study did
NCT00123656 · University of Utah
2004-08 – 2006-12 · Esophagitis
What this study did
NCT00206284 · AstraZeneca
2004-05 – 2005-04 · GERD Without Erosive Esophagitis
What this study did
NCT00206245 · AstraZeneca
2004-05 – 2005-03 · GERD With Erosive Esophagitis
What this study did
NCT00628953 · AstraZeneca
2002-10 – 2004-04 · Asthma
What this study did
Phase 1/2 (5)
Other / comorbidity
NCT06302049 · Sadat City University
2024-06-01 – 2026-05-01 · Fatty Liver Disease, Steatohepatitis, Nonalcoholic
What this study did
NCT05287633 · University of Monastir
2020-01-20 – 2024-12-30 · Dyspepsia
What this study did
NCT02473640 · Theriva Biologics, Inc.
2015-06 – 2016-04 · Healthy Volunteers With Ileostomy
What this study did
NCT01129713 · Effexus Pharmaceutical
2010-05 – 2015-05 · Gastroesophageal Reflux Disease (GERD), Heartburn, Indigestion
What this study did
NCT00564330 · Brain-Gut Research Group
2007-11 – 2008-05 · Tooth Erosion
What this study did
Phase 1 (73)
Helicobacter pylori Infection
NCT05100446 · Unidade Local de Saúde do Alto Ave, EPE
2021-05-01 – 2022-12-31 · Helicobacter Pylori Infection, Gastritis, Gastric Cancer
What this study did
Other / comorbidity
NCT06733675 · Basilea Pharmaceutica
2025-01-07 – 2026-12-30 · Healthy Volunteer, Pharmacokinetics, Safety, Drug-Drug Interaction (DDI), FDC
What this study did
NCT06717269 · Nurix Therapeutics, Inc.
2024-11-30 – 2026-05-01 · Healthy Volunteer
What this study did
NCT05232994 · Christiana Care Health Services
2023-03-01 – 2025-12-31 · Preeclampsia Severe, Preeclampsia Second Trimester, Preterm Birth Complication
What this study did
NCT07294846 · Jiangsu Sinorda Biomedicine Co., Ltd
2025-09-08 – 2025-12-15 · Healthy Volunteers, Patients
What this study did
NCT07018635 · Incyte Corporation
2025-07-16 – 2025-09-29 · Healthy Participants
What this study did
NCT06213818 · Incyte Corporation
2024-03-14 – 2025-08-19 · Healthy Participants
What this study did
NCT06233149 · Bio-innova Co., Ltd
2024-10-01 – 2024-12-03 · Healthy Subjects
What this study did
NCT06164834 · HK inno.N Corporation
2023-12-05 – 2024-11 · Healthy
What this study did
NCT06233097 · Bio-innova Co., Ltd
2024-08-29 – 2024-10-12 · Healthy Subjects
What this study did
NCT06419660 · Boehringer Ingelheim
2024-05-22 – 2024-07-08 · Healthy
What this study did
NCT06378658 · Bayer
2024-03-29 – 2024-06-11 · Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, Healthy Volunteers
What this study did
NCT06275841 · Pfizer
2024-02-23 – 2024-05-24 · Healthy
What this study did
NCT05688124 · Innovent Biologics (Suzhou) Co. Ltd.
2023-02-16 – 2023-10-16 · Healthy Subjects
What this study did
NCT05586568 · Xuanzhu Biopharmaceutical Co., Ltd.
2022-11-15 – 2023-08-02 · Healthy Subjects
What this study did
NCT05826574 · Insmed Incorporated
2023-05-10 – 2023-07-16 · Healthy Volunteers
What this study did
NCT05467475 · Boehringer Ingelheim
2022-10-18 – 2023-01-23 · Healthy
What this study did
NCT05265247 · HALEON
2022-03-02 – 2022-06-02 · Gastrointestinal Diseases
What this study did
NCT06181084 · Eli Lilly and Company
2021-10-11 – 2022-04-28 · Healthy
What this study did
NCT05051566 · Eli Lilly and Company
2021-09-16 – 2022-04-04 · Healthy
What this study did
NCT05061563 · Bayer
2021-09-30 – 2022-02-23 · Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes
What this study did
NCT04942652 · Seoul National University Hospital
2021-07-13 – 2021-08-24 · Achlorhydria
What this study did
NCT04568772 · Seoul National University Hospital
2020-11-25 – 2021-08-03 · Gastroesophageal Reflux Disease
What this study did
NCT05235217 · Future University in Egypt
2021-06-03 – 2021-06-18 · Bioequivalence
What this study did
NCT05513625 · AiCuris Anti-infective Cures AG
2020-07-13 – 2020-10-13 · HSV Infection
What this study did
NCT03980756 · Addpharma Inc.
2019-06-05 – 2020-06-18 · Gastritis
What this study did
NCT03985319 · Yooyoung Pharmaceutical Co., Ltd.
2019-07-08 – 2020-03-20 · GERD
What this study did
NCT04142762 · Assembly Biosciences
2019-10-18 – 2020-01-29 · Chronic Hepatitis B
What this study did
NCT04138836 · Bridge Biotherapeutics, Inc.
2019-09-17 – 2019-11-04 · Healthy Participants
What this study did
NCT03814642 · HK inno.N Corporation
2019-01-21 – 2019-07-22 · Healthy
What this study did
NCT03849690 · Millennium Pharmaceuticals, Inc.
2019-02-27 – 2019-04-15 · Healthy Volunteers
What this study did
NCT03372850 · Hanmi Pharmaceutical Company Limited
2018-02-15 – 2018-06-15 · Healthy
What this study did
NCT03444402 · Chong Kun Dang Pharmaceutical
2018-03-02 – 2018-05-04 · GERD
What this study did
NCT03558477 · Yooyoung Pharmaceutical Co., Ltd.
2017-09-19 – 2018-02-07 · GERD
What this study did
NCT03211143 · Chong Kun Dang Pharmaceutical
2017-06-20 – 2017-08-28 · GERD
What this study did
NCT02361619 · Turku University Hospital
2015-02 – 2017-06 · Healthy Volunteers
What this study did
NCT03083639 · Takeda
2017-03-27 – 2017-05-13 · Healthy Participants
What this study did
NCT03127046 · Dong Wha Pharmaceutical Co. Ltd.
2017-03-31 – 2017-04-23 · Healthy
What this study did
NCT01844583 · Millennium Pharmaceuticals, Inc.
2013-06-25 – 2016-09-06 · Solid Tumors, Lymphoma
What this study did
NCT02023125 · Hoffmann-La Roche
2013-12 – 2014-03 · Healthy Volunteer
What this study did
NCT01549574 · Pfizer
2012-05 – 2012-05 · Healthy
What this study did
NCT01135472 · City of Hope Medical Center
2010-07-13 – 2012-04-01 · Healthy
What this study did
NCT01448031 · AstraZeneca
2011-11 – 2012-04 · Healthy
What this study did
NCT01494402 · AstraZeneca
2012-01 – 2012-03 · Bioequivalence Study
What this study did
Phase 4 (129)
Helicobacter pylori Infection
NCT06509139 · National Cheng-Kung University Hospital
2024-07-09 – 2032-07-31 · Helicobacter Pylori Infection, Sex, Bismuth Quadruple Therapy
What this study did
NCT04527055 · National Cheng-Kung University Hospital
2020-05-06 – 2028-07-31 · Helicobacter Pylori Infection, Dysbiosis, Probiotics
What this study did
NCT07942987 · University of Thi-Qar
2026-01-20 – 2026-10-15 · HELICOBACTER PYLORI INFECTIONS
What this study did
NCT07139366 · Yongquan Shi
2025-10-28 – 2026-09 · Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
What this study did
NCT06959368 · Asian Institute of Gastroenterology, India
2025-03-25 – 2026-03-25 · Helicobacter Pylori Infection
What this study did
NCT05726734 · Shanghai East Hospital
2023-02-06 – 2026-02-06 · Helicobacter Pylori Infection
What this study did
NCT05874570 · Shanghai Jiao Tong University School of Medicine
2023-06-20 – 2025-10-31 · Helicobacter Pylori Infection
What this study did
NCT06318104 · Hospital General de México Dr. Eduardo Liceaga
2024-04-19 – 2025-02-28 · Helicobacter Pylori Infection
What this study did
NCT06603688 · Xijing Hospital of Digestive Diseases
2023-11-20 – 2024-12-01 · Helicobacter Pylori Infection, Chronic Gastritis
What this study did
NCT05742568 · Xijing Hospital of Digestive Diseases
2022-12-01 – 2024-03-10 · Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
What this study did
NCT05431075 · Shandong University
2022-07-01 – 2024-02-01 · Helicobacter Pylori Infection
What this study did
NCT06088316 · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2023-02-10 – 2024-02 · Helicobacter Pylori Infection, Helicobacter Pylori Eradication
What this study did
NCT05250050 · Shanghai Zhongshan Hospital
2022-03-25 – 2023-03-01 · Helicobacter Pylori Infection
What this study did
NCT04531059 · Shanghai Jiao Tong University School of Medicine
2020-10-15 – 2022-12-31 · Helicobacter Pylori Infection
What this study did
NCT04678492 · Xijing Hospital of Digestive Diseases
2020-12-20 – 2021-12-20 · Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
What this study did
NCT02553083 · Rabin Medical Center
2015-10-22 – 2021-12 · Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
What this study did
NCT04432233 · Shanghai Jiao Tong University School of Medicine
2020-06-15 – 2021-06-15 · Helicobacter Pylori Infection, Intravenous Drug Usage
What this study did
NCT04024527 · Shanghai Jiao Tong University School of Medicine
2019-07-25 – 2021-05-24 · Helicobacter Pylori Infection
What this study did
NCT03208426 · National Taiwan University Hospital
2017-10-01 – 2020-12-31 · Helicobacter Pylori Infection
What this study did
NCT03726099 · Shandong University
2019-03-15 – 2020-12-30 · Helicobacter Pylori Infection
What this study did
NCT04445948 · Alexandria University
2019-11-30 – 2020-06-21 · Helicobacter Pylori Infection
What this study did
NCT04090021 · Konstantopoulio-Patission General Hospital of Nea Ionia
2019-09-01 – 2020-02-28 · Helicobacter Pylori Infection
What this study did
NCT03220542 · Kyunghee University Medical Center
2016-01 – 2019-12-31 · Helicobacter Pylori Infection
What this study did
NCT02894268 · Sir Run Run Shaw Hospital
2016-02 – 2019-12 · Helicobacter Pylori Infection
What this study did
NCT03658733 · Shandong University
2018-12-15 – 2019-10-31 · Helicobacter Pylori Infection
What this study did
NCT03708848 · Shanghai Jiao Tong University School of Medicine
2018-12-05 – 2019-09-30 · Helicobacter Pylori Infection
What this study did
NCT03609892 · Xijing Hospital of Digestive Diseases
2018-08-01 – 2019-08-20 · Gastric Ulcer, Chronic Gastritis, Gastric Cancer, Helicobacter Pylori Infection, Gastritis
What this study did
NCT03557437 · Shanghai Jiao Tong University School of Medicine
2018-05-25 – 2019-06-10 · Helicobacter Pylori Infection
What this study did
NCT03730766 · Shanghai Jiao Tong University School of Medicine
2018-08-01 – 2018-11-20 · Helicobacter Pylori Infection
What this study did
NCT03405584 · Shanghai Jiao Tong University School of Medicine
2018-01-03 – 2018-11-02 · Helicobacter Pylori Infection
What this study did
NCT03413020 · Shanghai Jiao Tong University School of Medicine
2018-01-03 – 2018-07-31 · Helicobacter Pylori Infection
What this study did
NCT02935010 · Shanghai Jiao Tong University School of Medicine
2017-02-05 – 2018-03-31 · Helicobacter Pylori Infection
What this study did
NCT02959255 · Elpen Pharmaceutical Co. Inc.
2017-01-30 – 2017-12-30 · Helicobacter Pylori Infection
What this study did
NCT02732249 · Shanghai Jiao Tong University School of Medicine
2016-04-01 – 2017-09-30 · Helicobacter Pylori Infection
What this study did
NCT02711176 · Zahra Vahdat Shariatpanahi
2016-09 – 2017-03-27 · Helicobacter Infection
What this study did
NCT02045251 · American University of Beirut Medical Center
2013-06 – 2016-09 · Treatment of H. Pylori Infection
What this study did
NCT02552641 · EMS
2015-09 – 2016-09 · Helicobacter Pylori Infection
What this study did
NCT01887249 · Seoul National University Bundang Hospital
2010-05 – 2013-07 · Helicobacter Pylori Infection
What this study did
NCT00825630 · Meridian Bioscience, Inc.
2008-11 – 2009-11 · Helicobacter Pylori Infection
What this study did
Other / comorbidity
NCT04448028 · Universitätsklinikum Hamburg-Eppendorf
2021-04-22 – 2028-02 · Liver Cirrhosis
What this study did
NCT05320796 · Prof Urs Zingg
2023-11-01 – 2027-12-31 · Obesity, Gastric Reflux, Ulcer, Gastric
What this study did
NCT07312370 · LanZhou University
2026-04-20 – 2026-12-30 · Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms, Peptic Ulcer With Haemorrhage, Gastric Ulcer
What this study did
NCT06283381 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2024-02-01 – 2026-06-30 · Obesity
What this study did
NCT06359015 · Christiana Care Health Services
2021-02-11 – 2025-05-08 · Preeclampsia Severe, Pre-Eclampsia, Preeclampsia, Preeclampsia Second Trimester, Preeclampsia Complicating Childbirth, Preeclampsia Puerperium, Preterm
What this study did
NCT04918017 · University of Malaya
2021-11-18 – 2023-12-31 · Functional Dyspepsia
What this study did
NCT02476097 · Victoria Rollason
2015-06 – 2023-12 · Stomach Diseases
What this study did
NCT04558502 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2022-01-05 – 2022-12-05 · Helicobacter Pylori Eradication
What this study did
NCT03555526 · National Taiwan University Hospital
2017-12-15 – 2021-12-31 · H Pylori Infection
What this study did
NCT02456012 · Hsiu-Chi Cheng
2015-04 – 2020-12-31 · Peptic Ulcer Hemorrhage
What this study did
NCT05237115 · Xijing Hospital of Digestive Diseases
2020-05-05 – 2020-12-05 · Gastritis, Peptic Ulcer, Dyspepsia
What this study did
Early phase / not applicable (46)
Helicobacter pylori Infection
NCT07746934 · University of Medicine and Pharmacy at Ho Chi Minh City
2026-07-27 – 2027-12-27 · Helicobacter Pylori Infection
What this study did
NCT06250634 · The Third Xiangya Hospital of Central South University
2024-02-10 – 2024-05-10 · Helicobacter Pylori Infection
What this study did
NCT04359966 · Slovenian Society for Gastroenterology and Hepatology
2020-05-10 – 2023-09-30 · Helicobacter Pylori Infection, Eradication Treatments
What this study did
NCT05176821 · Shanghai Zhongshan Hospital
2021-01-01 – 2022-12-31 · H. Pylori Infection
What this study did
NCT04879992 · Shanghai Jiao Tong University School of Medicine
2021-05-07 – 2022-10-30 · Helicobacter Pylori Infection
What this study did
NCT05097846 · wang xiaoyan
2021-06-17 – 2022-10-17 · Helicobacter Pylori Infection
What this study did
NCT04991584 · Shandong University
2021-08-04 – 2022-07-01 · Helicobacter Pylori Infection
What this study did
NCT03688828 · Huazhong University of Science and Technology
2018-11-11 – 2020-12-31 · Helicobacter Pylori Infection
What this study did
NCT02894892 · National Taiwan University Hospital
2016-11-15 – 2019-02-20 · Helicobacter Pylori Infection
What this study did
NCT03383003 · Chang Gung Memorial Hospital
2016-03-01 – 2018-05-01 · Helicobacter Pylori Infection
What this study did
NCT02547012 · Kaohsiung Veterans General Hospital.
2013-11 – 2017-10 · Helicobacter Pylori Infection
What this study did
NCT02978157 · Kaohsiung Veterans General Hospital.
2015-02 – 2017-09 · Helicobacter Pylori Infection
What this study did
NCT02596620 · Chang Gung Memorial Hospital
2013-10 – 2015-11 · Helicobacter Pylori Infection
What this study did
NCT00520949 · Aga Khan University
2006-10 – 2008-06 · Treatment of Helicobacter Pylori
What this study did
Other / comorbidity
NCT06955520 · Asian Institute of Gastroenterology, India
2025-04-30 – 2028-12-25 · GERD
What this study did
NCT02373280 · Seoul National University Bundang Hospital
2014-08 – 2027-12 · Helicobacter Infection
What this study did
NCT07896577 · Changhai Hospital
2026-12 – 2027-08 · Malignant Gastric Outlet Obstruction
What this study did
NCT07790549 · Liaquat University of Medical & Health Sciences
2026-09-07 – 2027-01-29 · Non-Erosive Gastroesophageal Reflux Disease (NERD)
What this study did
NCT07563491 · Muhammad Aamir Latif
2025-01-01 – 2025-09-30 · Gastro Esophageal Reflux
What this study did
NCT05850117 · Kaohsiung Medical University
2020-02-10 – 2024-12-31 · Helicobacter Pylori Eradication
What this study did
NCT04720781 · Showa Inan General Hospital
2021-01-21 – 2024-12-31 · Gastroesophageal Reflux
What this study did
NCT03724838 · Aswan University Hospital
2018-12-01 – 2022-01-01 · Preeclampsia
What this study did
NCT03717701 · Aswan University Hospital
2018-12-01 – 2021-01-01 · Pre-Eclampsia
What this study did
NCT02081404 · Midwest Biomedical Research
2009-03-01 – 2020-08-05 · Non-erosive Reflux Disease
What this study did
NCT04329000 · Kaohsiung Veterans General Hospital.
2010-02-02 – 2019-12-08 · Barrett Esophagus, Proton Pump Inhibitor, Symptom, Reflux
What this study did
NCT04003350 · Rothman Institute Orthopaedics
2017-12-21 – 2019-03-15 · Osteo Arthritis Knee
What this study did
NCT02984930 · Gangnam Severance Hospital
2016-12 – 2018-07 · Gastroesophageal Reflux Disease
What this study did
NCT03598738 · Baskent University Ankara Hospital
2015-12-01 – 2017-12-01 · Diabetes Mellitus, Type 2
What this study did
NCT02730533 · Xijing Hospital of Digestive Diseases
2016-03 – 2017-04 · Stomach Neoplasms
What this study did
NCT03812419 · Future University in Egypt
2016-01-05 – 2016-12-30 · Kidney Transplant; Complications
What this study did
NCT01854970 · University Hospital, Bordeaux
2013-05 – 2015-07 · Laryngopharyngeal Reflux, Oesophageal pH-impedance
What this study did
NCT02071316 · Shaare Zedek Medical Center
2014-04 – 2015-04 · Upper Gastrointestinal Bleeding, Hexacapron, Hemostasis, Rebleeding, Mortality
What this study did
NCT02884713 · King Faisal Specialist Hospital & Research Center
2013-06 – 2014-04 · GASTRITIS
What this study did
NCT04407832 · Changhua Christian Hospital
2011-08 – 2013-09 · Peptic Ulcer Bleeding
What this study did
NCT01710800 · Walter Reed National Military Medical Center
2008-09 – 2012-09 · GERD
What this study did
NCT01079884 · David A. Johnson, MD
2008-07 – 2011-03 · GERD
What this study did
NCT00604942 · Guy's and St Thomas' NHS Foundation Trust
2007-11 – 2010-10 · Achalasia, GORD
What this study did
NCT00895817 · Walter Reed Army Medical Center
2008-04 – 2010-10 · Eosinophilic Esophagitis
What this study did
NCT01139645 · American University of Beirut Medical Center
2009-10 – 2010-07 · Calcium Metabolism Disorders
What this study did
NCT00786695 · National University Hospital, Singapore
2006-05 – 2009-12 · Gastroesophageal Reflux Disease
What this study did
NCT00516971 · Hospital Authority, Hong Kong
2003-01 – 2008-12 · Gastroesophageal Reflux
What this study did
NCT00745849 · University of Texas Southwestern Medical Center
2005-06 – 2008-03 · Vasomotor Rhinitis
What this study did
NCT00222079 · Douglas Trask
2004-11 – 2008-02 · Gastro-esophageal Reflux
What this study did
NCT00170001 · Mayo Clinic
2005-04 – 2006-08 · Gastroesophageal Reflux
What this study did
NCT00162877 · National Taiwan University Hospital
2004-06 – 2005-04 · Peptic Ulcer With H. Pylori Infection, Gastritis With H. Pylori Infection
What this study did
Used as active comparator (66)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (19)
Helicobacter pylori Infection
NCT07606833 · Xuanzhu Biopharmaceutical Co., Ltd.
2026-06-10 – 2027-03-18 · HELICOBACTER PYLORI INFECTIONS
What this study did
Other / comorbidity
NCT07931521 · Daewon Pharmaceutical Co., Ltd.
2025-11-17 – 2026-09-14 · Erosive Reflux Disease, GERD (Gastroesophageal Reflux Disease)
What this study did
NCT01471925 · Eurofarma Laboratorios S.A.
— · Gastroesophageal Reflux Disease
What this study did
NCT07326904 · Universitas Indonesia
2024-08-28 – 2024-12-13 · Gastro Oesophageal Reflux Disease
What this study did
NCT06162949 · Alexandria University
2024-01-01 – 2024-08-01 · Treatment Effectiveness
What this study did
NCT05443984 · Onconic Therapeutics Inc.
2022-01-17 – 2023-01-05 · Erosive Esophagitis
What this study did
NCT03943992 · Yooyoung Pharmaceutical Co., Ltd.
2019-01-29 – 2020-07-01 · Erosive Esophagitis
What this study did
NCT03967886 · Yooyoung Pharmaceutical Co., Ltd.
2019-04-10 – 2020-05-27 · Non-erosive Reflux Disease
What this study did
NCT03615677 · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
2018-10-24 – 2019-10-18 · Erosive Esophagitis (EE)
What this study did
NCT03736369 · Daewoong Pharmaceutical Co. LTD.
2018-12-13 – 2019-08-07 · Erosive Esophagitis
What this study did
NCT03006874 · HK inno.N Corporation
2016-05-02 – 2017-03-24 · Erosive Esophagitis
What this study did
NCT01670552 · EMS
2016-02-17 – 2017-03-17 · Acute and Chronic Inflammation, Dyspepsia
What this study did
NCT02456935 · HK inno.N Corporation
2015-05 – 2016-09 · Erosive Esophagitis
What this study did
NCT02860624 · Livzon Pharmaceutical Group Inc.
2011-12 – 2013-04 · Gastroesophageal Reflux Disease
What this study did
NCT00658775 · Eisai Inc.
2008-02 – 2010-01 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00658528 · Eisai Inc.
2008-02 – 2010-01 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00658632 · Eisai Inc.
2008-02 – 2009-09 · Gastroesophageal Reflux Disease (GERD)
What this study did
Phase 2 (8)
Other / comorbidity
NCT06783257 · Shandong New Time Pharmaceutical Co., LTD
2025-02 – 2027-02 · Peptic Ulcer Bleeding
What this study did
NCT04282954 · Onconic Therapeutics Inc.
2019-11-15 – 2020-12-11 · GERD
What this study did
NCT03184324 · Daewoong Pharmaceutical Co. LTD.
2017-08-28 – 2018-04-18 · Erosive Gastroesophageal Reflux Disease
What this study did
NCT01538849 · Yuhan Corporation
2012-12 – 2014-05 · Reflux Esophagitis
What this study did
NCT02028663 · HK inno.N Corporation
2013-05 – 2014-05 · Erosive Esophagitis, GERD
What this study did
NCT01750437 · Yuhan Corporation
2013-01 – 2014-04 · Non-erosive Reflux Disease
What this study did
NCT01107938 · Livzon Pharmaceutical Group Inc.
2010-05 – 2010-06 · Gastroesophageal Reflux Disease
What this study did
Phase 1 (14)
Other / comorbidity
NCT06561542 · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
2024-08-05 – 2025-01-23 · Healthy
What this study did
NCT04753437 · Takeda
2021-04-06 – 2021-11-05 · Helicobacter Pylori
What this study did
NCT03530228 · HK inno.N Corporation
2018-05 – 2018-08 · Pharmacodynamics, Pharmacokinetics, Healthy Male Volunteers
What this study did
NCT02757144 · Daewoong Pharmaceutical Co. LTD.
2016-03 – 2017-02 · Healthy
What this study did
NCT01216293 · Takeda
2010-11-01 – 2015-02-01 · Homeostasis, Bone and Bones
What this study did
NCT01921647 · Yuhan Corporation
2013-07 – 2013-11 · Healthy
What this study did
NCT01473173 · HK inno.N Corporation
2011-11 – 2012-08 · Healthy
What this study did
NCT01007019 · Yuhan Corporation
2009-11 – 2012-03 · Healthy
What this study did
NCT02680119 · Torrent Pharmaceuticals Limited
2011-05 – 2011-05 · Healthy
What this study did
NCT02680132 · Torrent Pharmaceuticals Limited
2011-05 – 2011-05 · Healthy
What this study did
NCT02659683 · Torrent Pharmaceuticals Limited
2011-05 – 2011-05 · Healthy Subjects
What this study did
NCT00749385 · POZEN
2008-08 – 2008-10 · Arthritis
What this study did
NCT00325715 · Allergan
2006-04 – 2006-08 · Peptic Ulcer
What this study did
Phase 4 (17)
Helicobacter pylori Infection
NCT07537634 · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2026-04-15 – 2026-09-14 · Helicobacter Pylori Infection, Dyspepsia, Peptic Ulcer Disease, Helicobacter Pylori, H Pylori
What this study did
NCT05647278 · Zhang Xiaofeng,MD
2023-11-01 – 2025-10-31 · Helicobacter Pylori Infection
What this study did
NCT06523764 · Xijing Hospital of Digestive Diseases
2024-11-11 – 2025-10-01 · Helicobacter Pylori Infection Chronic Gastrit
What this study did
NCT06514274 · Xijing Hospital of Digestive Diseases
2024-09-20 – 2025-06-25 · Helicobacter Pylori Infection, Chronic Gastritis
What this study did
NCT05590286 · First People's Hospital of Hangzhou
2022-06-01 – 2024-12-31 · Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor
What this study did
NCT06168084 · Yongquan Shi
2023-06-06 – 2024-08-30 · Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
What this study did
NCT04907747 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2021-05-18 – 2022-04-13 · Helicobacter Pylori Infection
What this study did
NCT03908619 · Changi General Hospital
2019-04-16 – 2021-03-31 · Helicobacter Pylori Infection
What this study did
Other / comorbidity
NCT06526455 · Shicai Ye
2024-12-02 – 2029-06-30 · Ulcers, Gastric
What this study did
NCT05582174 · Chinese University of Hong Kong
2023-05-18 – 2028-07-03 · Upper GI Bleeding, Proton Pump Inhibitors
What this study did
NCT07268820 · Incheon St.Mary's Hospital
2025-07-07 – 2026-09-30 · GERD
What this study did
NCT06720610 · Universitas Indonesia
2024-12-09 – 2025-06-27 · Erosive Esophagitis
What this study did
NCT05701540 · HK inno.N Corporation
2023-03-24 – 2024-12-31 · Gastroesophageal Reflux Disease
What this study did
NCT05196945 · Sixth Affiliated Hospital, Sun Yat-sen University
2022-03-31 – 2023-02-28 · Helicobacter Pylori Eradication Rate
What this study did
NCT04309916 · HK inno.N Corporation
2020-05-22 – 2021-11-30 · Erosive Reflux Disease
What this study did
NCT02530879 · Temple University
2016-05 – 2018-01 · Laryngopharyngeal Reflux
What this study did
NCT00184522 · Norwegian University of Science and Technology
2002-08 – 2004-12 · Gastroesophageal Reflux
What this study did
Early phase / not applicable (8)
Helicobacter pylori Infection
NCT06382493 · Seoul National University Bundang Hospital
2021-02-01 – 2026-12-12 · Helicobacter Pylori Infection
What this study did
NCT05870683 · Yanqing Li
2023-05-24 – 2023-12-30 · Helicobacter Pylori Infection
What this study did
NCT05189444 · Huazhong University of Science and Technology
2022-03-25 – 2022-12-31 · Helicobacter Pylori Infection
What this study did
Other / comorbidity
NCT07791849 · First Affiliated Hospital of Zhejiang University
2026-09-15 – 2028-12-31 · Hematopoietic Stem Cell Transplantation (HSCT), aGVHD, Infection, Mortality, Microbiome
What this study did
NCT07772700 · National Cheng-Kung University Hospital
2026-09-01 – 2027-12-31 · Bleeding
What this study did
NCT06953986 · Asian Institute of Gastroenterology, India
2025-12-20 – 2027-12-12 · GERD
What this study did
NCT06851468 · Key Laboratory for Gastrointestinal Diseases of Gansu Province
2025-03-15 – 2025-11-30 · Helicobacter Pylori
What this study did
NCT03040817 · Zhongda Hospital
2017-09-01 – 2019-12-16 · Gastric Peroral Endoscopic Pyloromyotomy (G-POEM)
What this study did
Appears in other studies (10)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 2 (2)
Other / comorbidity
NCT02307305 · Hanyang University Seoul Hospital
2014-08 – 2016-12 · Neuropathic Pain
What this study did
NCT00730665 · Pfizer
2008-01 – 2008-10 · Gastroesophageal Reflux Disease
What this study did
Phase 1 (5)
Other / comorbidity
NCT06793943 · Takeda
2025-01-23 – 2025-03-30 · Healthy Volunteers
What this study did
NCT06366243 · Cerevel Therapeutics, LLC
2024-05-10 – 2024-06-20 · Healthy Participants
What this study did
NCT04156646 · Hoffmann-La Roche
2019-11-19 – 2020-01-06 · Autism Spectrum Disorder
What this study did
NCT02128893 · Astellas Pharma Global Development, Inc.
2014-01 – 2014-02 · Pharmacokinetics of Isavuconazole, Healthy Subjects
What this study did
NCT00963027 · United Therapeutics
2009-09 – 2009-10 · Hypertension, Pulmonary, Pulmonary Arterial Hypertension
What this study did
Early phase / not applicable (3)
Other / comorbidity
NCT07910656 · University of Medicine and Pharmacy at Ho Chi Minh City
2026-03-20 – 2026-08-31 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT02741414 · Taizhou Hospital
2016-06 – 2018-12 · Gastritis
What this study did
NCT02840929 · The University of Hong Kong
2016-07 – 2017-09 · OGD, Gastric Ulcer Induced by Anti-platelet Agent, Duodenal Ulcer Induced by Anti-platelet Agent
What this study did

Competitive landscape

Other H+/K+-ATPase (gastric proton pump) drugs

Rabeprazole. Compare all 2 H+/K+-ATPase (gastric proton pump) drugs

1 other tracked programme targets this mechanism, none of them ahead of this one.

This drug's own stage for Helicobacter pylori Infection: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Esomeprazole (Nexium): this drugApprovedSmall moleculeH+/K+-ATPase (gastric proton pump)not yet gradedNo reviewed efficacy summary in this indication
Omeprazole, Amoxicillin, And Rifabutin (Talicia)ApprovedSmall moleculeH. pylori eradication (PPI + amoxicillin + rifabutin)Reliable signal
NCT03198507: Number of Participants With Eradication of H. Pylori (43-71 days after initiation of treatment): RHB-105 191 Participants | Active Comparator 131 Participants
NCT01980095: The Occurrence of H. Pylori Eradication as Confirmed Via 13C UBT Testing (28-56 days after completion of treatment): RHB-105 — H. pylori eradication success: 59 Participants; H. pylori eradication failure: 7 Participants | Placebo — H. pylori eradication success: 1 Participants; H. pylori eradication failure: 36 Participants
Rabeprazole (Aciphex)ApprovedSmall moleculeH+/K+-ATPase (gastric proton pump)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(15 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Nexium (Esomeprazole) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (2)
December 2026 (2)
Phase 4Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms, Peptic Ulcer With Haemorrhage, Gastric UlcerNot yet recruiting
Est. primary completion 2026-12-20 · NCT07312370 · CT.gov ↗
What to watch
Phase 1Healthy Volunteer, Pharmacokinetics, Safety, Drug-Drug Interaction (DDI), FDCRecruiting
Est. primary completion 2026-12-30 · NCT06733675 · CT.gov ↗
What to watch
2027 (7)
January 2027 (1)
Early phase / not applicableNon-Erosive Gastroesophageal Reflux Disease (NERD)Not yet recruiting
Est. primary completion 2027-01-29 · NCT07790549 · CT.gov ↗
What to watch
April 2027 (1)
Early phase / not applicableHelicobacter InfectionRecruiting
Est. primary completion 2027-04 · NCT02373280 · CT.gov ↗
What to watch
June 2027 (1)
Early phase / not applicableMalignant Gastric Outlet ObstructionNot yet recruiting
Est. primary completion 2027-06 · NCT07896577 · CT.gov ↗
What to watch
August 2027 (1)
Early phase / not applicableHelicobacter pylori InfectionNot yet recruiting
Est. primary completion 2027-08-27 · NCT07746934 · CT.gov ↗
What to watch
December 2027 (3)
Early phase / not applicableGERDRecruiting
Est. primary completion 2027-12-10 · NCT06955520 · CT.gov ↗
What to watch
Phase 2Radiation Esophagitis, Locally Advanced Lung CarcinomaRecruiting
Est. primary completion 2027-12-30 · NCT06120803 · CT.gov ↗
What to watch
Phase 4Obesity, Gastric Reflux, Ulcer, GastricRecruiting
Est. primary completion 2027-12-31 · NCT05320796 · CT.gov ↗
What to watch
2028 (3)
February 2028 (1)
Phase 4Liver CirrhosisRecruiting
Est. primary completion 2028-02 · NCT04448028 · CT.gov ↗
What to watch
July 2028 (1)
Phase 4Helicobacter pylori InfectionEnrolling by invitation
Est. primary completion 2028-07-31 · NCT04527055 · CT.gov ↗
What to watch
December 2028 (1)
Phase 2Autism, Autism Spectrum DisorderRecruiting
Est. primary completion 2028-12 · NCT03866668 · CT.gov ↗
What to watch
2029 (2)
April 2029 (1)
Phase 2Bone Pain Flare, Bone MetastasisNot yet recruiting
Est. primary completion 2029-04 · NCT06903585 · CT.gov ↗
What to watch
December 2029 (1)
Phase 2MALT Lymphoma of StomachNot yet recruiting
Est. primary completion 2029-12-31 · NCT07144657 · CT.gov ↗
What to watch
2032 (1)
July 2032 (1)
Phase 4Helicobacter pylori InfectionEnrolling by invitation
Est. primary completion 2032-07-31 · NCT06509139 · CT.gov ↗
What to watch

See the full readout calendar ↗